FRESENIUS KABI MALAYSIA SDN BHD — Oxaliplatin Importer Profile
Pharmaceutical Importer · #11 buyer for Oxaliplatin · $657.5K import value · 23 shipments · MALAYSIA · DGFT Verified
FRESENIUS KABI MALAYSIA SDN BHD is the #11 importer of Oxaliplatin from India with $657.5K in import value and 23 verified shipments. FRESENIUS KABI MALAYSIA SDN BHD holds a 1.5% market share in Oxaliplatin imports based in MALAYSIA. The company sources from 1 verified supplier across 18 formulations shipped to 1 country. Overall, FRESENIUS KABI MALAYSIA SDN BHD imports 8 pharmaceutical products worth $3.5M across 2 therapeutic categories.
FRESENIUS KABI MALAYSIA SDN BHD — Oxaliplatin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Oxaliplatin to FRESENIUS KABI MALAYSIA SDN BHD?
Verified from 23 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| FRESENIUS KABI ONCOLOGY LIMITED | $657.5K | 23 | 100.0% |
FRESENIUS KABI MALAYSIA SDN BHD sources Oxaliplatin from 1 verified Indian supplier based on 23 customs records. The primary supplier is FRESENIUS KABI ONCOLOGY LIMITED accounting for 100.0% of imports.
How Does FRESENIUS KABI MALAYSIA SDN BHD Compare to Nearest Oxaliplatin Importers?
Buyers ranked immediately above and below #11 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | OOO"JODAS EXPOIM" | RUSSIA | $800.0K | 16 | $50.0K |
| 9 | FRESENIUS KABI COLOMBIA SAS | COLOMBIA | $782.8K | 17 | $46.0K |
| 11 | FRESENIUS KABI MALAYSIA SDN BHD ★ | MALAYSIA | $696.5K | 19 | $36.7K |
| 6 | FRESENIUS KABI (THAILAND) LTD | THAILAND | $650.0K | 13 | $50.0K |
| 14 | C M C L | THAILAND | $620.1K | 27 | $23.0K |
FRESENIUS KABI MALAYSIA SDN BHD ranks #11 among 693 Oxaliplatin importers from India. Average shipment value of $36.7K compared to the market average of $29.9K. The closest competitors by value are OOO"JODAS EXPOIM" and FRESENIUS KABI COLOMBIA SAS.
Where Does FRESENIUS KABI MALAYSIA SDN BHD Import Oxaliplatin To?
Destination countries from 23 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALAYSIA | $657.5K | 23 | 100.0% |
FRESENIUS KABI MALAYSIA SDN BHD imports Oxaliplatin to 1 country. The primary destination is MALAYSIA receiving 100.0% of shipments worth $657.5K.
What Oxaliplatin Formulations Does FRESENIUS KABI MALAYSIA SDN BHD Import?
| Formulation | Value | Shipments |
|---|---|---|
| OXITAN OXALIPLATIN INJ. 50MG/10ML VIALB/N: 87230416AB 87230416AC MD:09/23 ED:08/25 | $150.0K | 3 |
| OXITAN (OXALIPLATIN) INJ. 50MG/10ML VIAL | $83.3K | 3 |
| OXITANOXALIPLATININJ.100MG/20ML VIALB NO-87230396BA MANUFACTURING .DT. 08/2023 EXP.DT. 07/2025 | $50.0K | 1 |
| OXITAN (OXALIPLATIN) INJ. 50MG/10ML VIAL, BATCH NO. 87240099AA, MFG. DT. 02/2024, EXP. DT. 01/2026 | $50.0K | 1 |
| OXITAN (OXALIPLATIN) INJ. 50MG/10ML VIAL, BATCH NO. 87250025AC, MFG. DT. 02/2025, EXP. DT. 01/2027 | $50.0K | 1 |
| OXITAN(OXALIPLATIN)INJ.50MG/10ML VIALB NO-87240151AAMFG.04/2024 EXP.DT. 03/2026 | $45.3K | 1 |
| OXITAN (OXALIPLATIN) INJ. 100MG/20ML VIA | $40.5K | 2 |
| OXITAN (OXALIPLATIN) INJ. 50MG/10ML VIAL(BATCH NO. 87250056AA, MFG. DT. 02/2025, EXP. DT. 01/2027) | $33.2K | 1 |
| OXITAN OXALIPLATIN INJ 100MG 20ML VIAL B N 87230093AA 87230094AB MD 02 23 ED 01 25 | $30.8K | 1 |
| OXITAN (OXALIPLATIN) USP INJ. 100MG/20MLVIAL (BATCH NO. 87250065AA, MFG. DT. 03/2025, EXP. DT. 02/2027) | $30.2K | 1 |
FRESENIUS KABI MALAYSIA SDN BHD imports 18 distinct Oxaliplatin formulations from India. The top formulation is OXITAN OXALIPLATIN INJ. 50MG/10ML VIALB/N: 87230416AB 872304 with 3 shipments worth $150.0K.
Who Are the Top Buyers of Oxaliplatin from India and How Much Does FRESENIUS KABI MALAYSIA SDN BHD Import?
India exported $20.7M worth of Oxaliplatin through 3,081 shipments from 249 suppliers to 123 countries, serving 693 buyers globally. FRESENIUS KABI MALAYSIA SDN BHD imports $657.5K of this total, accounting for 1.5% of India's Oxaliplatin exports with 23 shipments from MALAYSIA. This is verified from 23 customs shipment records covering 18 distinct formulations.
What Is the Average Order Value for FRESENIUS KABI MALAYSIA SDN BHD's Oxaliplatin Imports?
FRESENIUS KABI MALAYSIA SDN BHD's average Oxaliplatin order value is $28.6K per consignment, based on 23 shipments totaling $657.5K. FRESENIUS KABI MALAYSIA SDN BHD is based in MALAYSIA and ranks #11 among all Oxaliplatin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Oxaliplatin to FRESENIUS KABI MALAYSIA SDN BHD?
FRESENIUS KABI MALAYSIA SDN BHD sources Oxaliplatin from 1 verified Indian supplier: FRESENIUS KABI ONCOLOGY LIMITED ($657.5K, 100.0%). This is based on 23 customs records.
How Does FRESENIUS KABI MALAYSIA SDN BHD Compare to Other Oxaliplatin Importers?
FRESENIUS KABI MALAYSIA SDN BHD ranks #11 among 693 Oxaliplatin importers from India with a 1.5% market share. The top 3 importers are FRESENIUS KABI DEUTSCHLAND GMBH ($10.0M), PHARMACIE CENTRALE DES HOPITAUX ($2.3M), YUSEN LOGISTICS BENELUX BELGIUM ($2.2M). FRESENIUS KABI MALAYSIA SDN BHD processed 23 shipments from MALAYSIA.
What Other Advanced Oncology Products Does FRESENIUS KABI MALAYSIA SDN BHD Import?
FRESENIUS KABI MALAYSIA SDN BHD also imports these advanced oncology products. Each links to the detailed product page.
About FRESENIUS KABI MALAYSIA SDN BHD
FRESENIUS KABI MALAYSIA SDN BHD imports 8 products worth $3.5M. Beyond Oxaliplatin, top products include Carboplatin, Docetaxel, Epirubicin, Gemcitabine, Cytarabine. View the complete FRESENIUS KABI MALAYSIA SDN BHD profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Oxaliplatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Oxaliplatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: FRESENIUS KABI MALAYSIA SDN BHD matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as FRESENIUS KABI MALAYSIA SDN BHD's capped import value divided by total capped export value for Oxaliplatin across all Indian exporters.
- 5.Verified Records: This page is backed by 23 individual customs records matching FRESENIUS KABI MALAYSIA SDN BHD importing Oxaliplatin, covering 18 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 693+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Oxaliplatin Import Data for FRESENIUS KABI MALAYSIA SDN BHD
Access order-level details, pricing data, supplier connections, and competitive analysis for FRESENIUS KABI MALAYSIA SDN BHD's Oxaliplatin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
FRESENIUS KABI MALAYSIA SDN BHD
Full Company Profile →
8 products · $3.5M total trade · 2 categories
FRESENIUS KABI MALAYSIA SDN BHD × Oxaliplatin
Verified from customs records
Company Overview
Top Products by FRESENIUS KABI MALAYSIA SDN BHD
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for FRESENIUS KABI MALAYSIA SDN BHD.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Oxaliplatin. For current order-level data, contact TransData Nexus.